Simplifying MND research with our 'Back to Basics' blog series
13 August 2024
A series of blogs, developed alongside a group of people affected by MND, designed to break down MND research into easy to understand chunks has launched
Disappointingly, the wait for the final results of the MIROCALS trial, testing Interleukin-2 as a treatment for motor neurone disease (MND), continues.
We will share resources to the email address you provide. The email will include your name in the subject line and the following message: 'I have found these information resources that you may find helpful too.'
Email sent successfully
We have shared these resources with the email address you entered.